Review



primary antibodies directed against slc2a1  (ZenBio)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    ZenBio primary antibodies directed against slc2a1
    Target genes for seven miRNAs and consensus genes and key genes in CESC. (A) miR‐505‐5p, (B) miR‐425‐5p, (C) miR‐331‐3p, (D) miR‐502‐3P, (E) miR‐629‐3p, (F) miR‐100‐3p, (G) miR‐301a‐5p. (H) The overlap between 86 DEGs and 176 target genes. (I) The association of <t>SLC2A1</t> with patients' prognosis of cervical cancer. (J) The association of TXNIP with patients' prognosis of cervical cancer. (K) The association of ANO6 with patients' prognosis of cervical cancer. (L) Network shows the intricate interplay between miRNAs and their target genes. Red denotes upregulated; green denotes downregulated.
    Primary Antibodies Directed Against Slc2a1, supplied by ZenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies directed against slc2a1/product/ZenBio
    Average 90 stars, based on 1 article reviews
    primary antibodies directed against slc2a1 - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Identification and Experimental Validation of Prognostic miRNA Signature and Ferroptosis‐Related Key Genes in Cervical Squamous Cell Carcinoma"

    Article Title: Identification and Experimental Validation of Prognostic miRNA Signature and Ferroptosis‐Related Key Genes in Cervical Squamous Cell Carcinoma

    Journal: Cancer Medicine

    doi: 10.1002/cam4.70415

    Target genes for seven miRNAs and consensus genes and key genes in CESC. (A) miR‐505‐5p, (B) miR‐425‐5p, (C) miR‐331‐3p, (D) miR‐502‐3P, (E) miR‐629‐3p, (F) miR‐100‐3p, (G) miR‐301a‐5p. (H) The overlap between 86 DEGs and 176 target genes. (I) The association of SLC2A1 with patients' prognosis of cervical cancer. (J) The association of TXNIP with patients' prognosis of cervical cancer. (K) The association of ANO6 with patients' prognosis of cervical cancer. (L) Network shows the intricate interplay between miRNAs and their target genes. Red denotes upregulated; green denotes downregulated.
    Figure Legend Snippet: Target genes for seven miRNAs and consensus genes and key genes in CESC. (A) miR‐505‐5p, (B) miR‐425‐5p, (C) miR‐331‐3p, (D) miR‐502‐3P, (E) miR‐629‐3p, (F) miR‐100‐3p, (G) miR‐301a‐5p. (H) The overlap between 86 DEGs and 176 target genes. (I) The association of SLC2A1 with patients' prognosis of cervical cancer. (J) The association of TXNIP with patients' prognosis of cervical cancer. (K) The association of ANO6 with patients' prognosis of cervical cancer. (L) Network shows the intricate interplay between miRNAs and their target genes. Red denotes upregulated; green denotes downregulated.

    Techniques Used:

    12 consensus genes.
    Figure Legend Snippet: 12 consensus genes.

    Techniques Used:

    Biological functions of differentially expressed genes and key genes. (A) Bar plots showing GO analysis for BP. (B) Bar plots showing GO analysis for MF. (C) Bar plots showing GO analysis for CC. (D) Circos plots of KEGG analysis. (E) Box plots of expression levels of key genes. * p < 0.05, ** p < 0.01, **** p < 0.001. (F) The single‐gene GSEA analysis of SLC2A1. (G) The single‐gene GSEA analysis of TXNIP.
    Figure Legend Snippet: Biological functions of differentially expressed genes and key genes. (A) Bar plots showing GO analysis for BP. (B) Bar plots showing GO analysis for MF. (C) Bar plots showing GO analysis for CC. (D) Circos plots of KEGG analysis. (E) Box plots of expression levels of key genes. * p < 0.05, ** p < 0.01, **** p < 0.001. (F) The single‐gene GSEA analysis of SLC2A1. (G) The single‐gene GSEA analysis of TXNIP.

    Techniques Used: Expressing

    Drug sensitivity and experimental verification of miRNA signature and key genes. (A) Scatter diagram of the relationship between consensus genes and drug sensitivity. (B) Network diagram of miRNA and target gene and drug correlation. (C) Differential expression of miR‐301a‐5p between cervical squamous cell carcinoma tumor and paracancerous tissues. (D) Differential expression of miR‐505‐5p between cervical squamous cell carcinoma tumor and paracancerous tissues. (E) SLC2A1 expression in cervical cancer and paracancerous tissues. (F) TXNIP expression in cervical cancer and paracancerous tissues. (G) The Stripe plots of Western Blotting analysis. * p < 0.05, ** p < 0.01, **** p < 0.001.
    Figure Legend Snippet: Drug sensitivity and experimental verification of miRNA signature and key genes. (A) Scatter diagram of the relationship between consensus genes and drug sensitivity. (B) Network diagram of miRNA and target gene and drug correlation. (C) Differential expression of miR‐301a‐5p between cervical squamous cell carcinoma tumor and paracancerous tissues. (D) Differential expression of miR‐505‐5p between cervical squamous cell carcinoma tumor and paracancerous tissues. (E) SLC2A1 expression in cervical cancer and paracancerous tissues. (F) TXNIP expression in cervical cancer and paracancerous tissues. (G) The Stripe plots of Western Blotting analysis. * p < 0.05, ** p < 0.01, **** p < 0.001.

    Techniques Used: Quantitative Proteomics, Expressing, Western Blot



    Similar Products

    primary antibodies directed against slc2a1  (ZenBio)
    90
    ZenBio primary antibodies directed against slc2a1
    Target genes for seven miRNAs and consensus genes and key genes in CESC. (A) miR‐505‐5p, (B) miR‐425‐5p, (C) miR‐331‐3p, (D) miR‐502‐3P, (E) miR‐629‐3p, (F) miR‐100‐3p, (G) miR‐301a‐5p. (H) The overlap between 86 DEGs and 176 target genes. (I) The association of <t>SLC2A1</t> with patients' prognosis of cervical cancer. (J) The association of TXNIP with patients' prognosis of cervical cancer. (K) The association of ANO6 with patients' prognosis of cervical cancer. (L) Network shows the intricate interplay between miRNAs and their target genes. Red denotes upregulated; green denotes downregulated.
    Primary Antibodies Directed Against Slc2a1, supplied by ZenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies directed against slc2a1/product/ZenBio
    Average 90 stars, based on 1 article reviews
    primary antibodies directed against slc2a1 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Target genes for seven miRNAs and consensus genes and key genes in CESC. (A) miR‐505‐5p, (B) miR‐425‐5p, (C) miR‐331‐3p, (D) miR‐502‐3P, (E) miR‐629‐3p, (F) miR‐100‐3p, (G) miR‐301a‐5p. (H) The overlap between 86 DEGs and 176 target genes. (I) The association of SLC2A1 with patients' prognosis of cervical cancer. (J) The association of TXNIP with patients' prognosis of cervical cancer. (K) The association of ANO6 with patients' prognosis of cervical cancer. (L) Network shows the intricate interplay between miRNAs and their target genes. Red denotes upregulated; green denotes downregulated.

    Journal: Cancer Medicine

    Article Title: Identification and Experimental Validation of Prognostic miRNA Signature and Ferroptosis‐Related Key Genes in Cervical Squamous Cell Carcinoma

    doi: 10.1002/cam4.70415

    Figure Lengend Snippet: Target genes for seven miRNAs and consensus genes and key genes in CESC. (A) miR‐505‐5p, (B) miR‐425‐5p, (C) miR‐331‐3p, (D) miR‐502‐3P, (E) miR‐629‐3p, (F) miR‐100‐3p, (G) miR‐301a‐5p. (H) The overlap between 86 DEGs and 176 target genes. (I) The association of SLC2A1 with patients' prognosis of cervical cancer. (J) The association of TXNIP with patients' prognosis of cervical cancer. (K) The association of ANO6 with patients' prognosis of cervical cancer. (L) Network shows the intricate interplay between miRNAs and their target genes. Red denotes upregulated; green denotes downregulated.

    Article Snippet: Thereafter, the membranes were incubated with primary antibodies directed against SLC2A1 (1:500, ZENBIO, 380464), TXNIP (1:500, Abcam, ab188865), and GAPDH (1:10,000, Abcam, ab8245) overnight.

    Techniques:

    12 consensus genes.

    Journal: Cancer Medicine

    Article Title: Identification and Experimental Validation of Prognostic miRNA Signature and Ferroptosis‐Related Key Genes in Cervical Squamous Cell Carcinoma

    doi: 10.1002/cam4.70415

    Figure Lengend Snippet: 12 consensus genes.

    Article Snippet: Thereafter, the membranes were incubated with primary antibodies directed against SLC2A1 (1:500, ZENBIO, 380464), TXNIP (1:500, Abcam, ab188865), and GAPDH (1:10,000, Abcam, ab8245) overnight.

    Techniques:

    Biological functions of differentially expressed genes and key genes. (A) Bar plots showing GO analysis for BP. (B) Bar plots showing GO analysis for MF. (C) Bar plots showing GO analysis for CC. (D) Circos plots of KEGG analysis. (E) Box plots of expression levels of key genes. * p < 0.05, ** p < 0.01, **** p < 0.001. (F) The single‐gene GSEA analysis of SLC2A1. (G) The single‐gene GSEA analysis of TXNIP.

    Journal: Cancer Medicine

    Article Title: Identification and Experimental Validation of Prognostic miRNA Signature and Ferroptosis‐Related Key Genes in Cervical Squamous Cell Carcinoma

    doi: 10.1002/cam4.70415

    Figure Lengend Snippet: Biological functions of differentially expressed genes and key genes. (A) Bar plots showing GO analysis for BP. (B) Bar plots showing GO analysis for MF. (C) Bar plots showing GO analysis for CC. (D) Circos plots of KEGG analysis. (E) Box plots of expression levels of key genes. * p < 0.05, ** p < 0.01, **** p < 0.001. (F) The single‐gene GSEA analysis of SLC2A1. (G) The single‐gene GSEA analysis of TXNIP.

    Article Snippet: Thereafter, the membranes were incubated with primary antibodies directed against SLC2A1 (1:500, ZENBIO, 380464), TXNIP (1:500, Abcam, ab188865), and GAPDH (1:10,000, Abcam, ab8245) overnight.

    Techniques: Expressing

    Drug sensitivity and experimental verification of miRNA signature and key genes. (A) Scatter diagram of the relationship between consensus genes and drug sensitivity. (B) Network diagram of miRNA and target gene and drug correlation. (C) Differential expression of miR‐301a‐5p between cervical squamous cell carcinoma tumor and paracancerous tissues. (D) Differential expression of miR‐505‐5p between cervical squamous cell carcinoma tumor and paracancerous tissues. (E) SLC2A1 expression in cervical cancer and paracancerous tissues. (F) TXNIP expression in cervical cancer and paracancerous tissues. (G) The Stripe plots of Western Blotting analysis. * p < 0.05, ** p < 0.01, **** p < 0.001.

    Journal: Cancer Medicine

    Article Title: Identification and Experimental Validation of Prognostic miRNA Signature and Ferroptosis‐Related Key Genes in Cervical Squamous Cell Carcinoma

    doi: 10.1002/cam4.70415

    Figure Lengend Snippet: Drug sensitivity and experimental verification of miRNA signature and key genes. (A) Scatter diagram of the relationship between consensus genes and drug sensitivity. (B) Network diagram of miRNA and target gene and drug correlation. (C) Differential expression of miR‐301a‐5p between cervical squamous cell carcinoma tumor and paracancerous tissues. (D) Differential expression of miR‐505‐5p between cervical squamous cell carcinoma tumor and paracancerous tissues. (E) SLC2A1 expression in cervical cancer and paracancerous tissues. (F) TXNIP expression in cervical cancer and paracancerous tissues. (G) The Stripe plots of Western Blotting analysis. * p < 0.05, ** p < 0.01, **** p < 0.001.

    Article Snippet: Thereafter, the membranes were incubated with primary antibodies directed against SLC2A1 (1:500, ZENBIO, 380464), TXNIP (1:500, Abcam, ab188865), and GAPDH (1:10,000, Abcam, ab8245) overnight.

    Techniques: Quantitative Proteomics, Expressing, Western Blot